bioRxiv Science⌕ Search

Biology subjects

Readhead, B. P.

Publications and source records attributed to Readhead, B. P..

3 recordsLinked to original sources

Upregulation of the Proto-Oncogene Src Kinase in Alzheimer's Disease: From Molecular Interactions to Therapeutic Potential

Alzheimers disease (AD) is a progressive neurodegenerative disease, resulting in an irreversible deterioration of multiple brain regions associated with cognitive dysfunction. Phosphorylation of the microtubule-associated protein, Tau, is known to occur decades before symptomatic AD. The Src family of tyrosine kinases are known to phosphorylate select tyrosine sites on Tau and promote microtubule disassembly and subsequent neurofibrillary tangle (NFT) formation. Our data show that the proto-oncogene, non-receptor tyrosine kinase Src colocalizes with a range of late (PHF1) to early (MC1) AD-associated phosphorylated Tau epitopes. The strongest co-occurrence is seen with MC1 (probability of MC1 given Src =100%), an early AD-specific conformational dependent epitope. Single-cell RNA sequencing data of 101 subjects show that Src is upregulated in both AD inhibitory and excitatory neurons. The most significantly affected, by orders of magnitude, were excitatory neurons which are the most prone to pathological Tau accumulation. We measured Src phosphorylation by mass spectrometry across a cohort of 48 patient neocortical tissues and found that Src has increased phosphorylation on Ser75, Tyr187, and Tyr440 in AD, showing that Src kinase undergoes distinct phosphorylation alterations in AD. Through Brownian dynamics simulations of Src and Tau, we show that as Tau undergoes the transition into disease-associated paired helical filaments, there is a notable seven-fold increase in Src contact with Tau. These results collectively emphasize Src kinases central role in Tau phosphorylation and its close association with Tau epitopes, presenting a promising target for potential therapeutic intervention.

neuroscience↗

Interpretable deep learning framework towards understanding molecular changes in human brains with Alzheimer's disease: implication for microglia activation and sex differences in AD

INTRODUCTIONThe objective of this study is to characterize the dysregulation of gene expression in AD affected brain tissues through an interpretable deep learning framework. METHODSWe trained multi-layer perceptron models for the classification of neuropathologically confirmed AD vs. controls using transcriptomic data from three brain regions of ROSMAP study. The disease spectrum was then modeled as a progressive trajectory. SHAP value was derived to explain model predictions and identify significantly implicated genes for subsequent gene co-expression network analysis. RESULTSThe models achieved excellent performance in classification and prediction in two external datasets from Mayo RNA-seq cohort and Mount Sinai Brain Bank cohort. SHAP explainer revealed common and specific transcriptomic signatures from different brain regions. DISCUSSIONWe identified common gene signatures among different brain regions in microglia and sex specific modules in neurons implicated in AD. This work paves the way for utilizing artificial intelligence approaches in studying AD at the molecular level. Research-in-ContextO_LISystematic review: Postmortem brain transcriptomes have been analyzed to study the molecular changes associated with Alzheimers disease, usually by a direct contrast approach such as differential gene expression analysis. Nuanced gene regulatory networks thus cannot be easily pinpointed from convoluted data such as those from bulk-tissue profiling. We applied a novel interpretable deep learning approach to dissect the RNA-seq data collected from three different brain regions of a large clinical cohort and identified significant genes for network analysis implicated for AD. C_LIO_LIInterpretation: Our models successfully predicted neuropathological and clinical traits in both internal and external validations. We corroborated known microglial biology in addition to revealing novel sex chromosome-linked gene contributing to sex dimorphism in AD. C_LIO_LIFuture directions: The framework could have broad utility for interpreting multi-omic data such as those from single-cell profiling, to advance our understanding of molecular mechanisms of complex human disease such as AD. C_LI HighlightsO_LIWe applied novel interpretable deep learning methods to postmortem brain transcriptomes from three different brain regions C_LIO_LIWe interpreted the models to identify genes most strongly implicated in AD C_LIO_LINetwork analysis corroborated known microglial biology and revealed novel sex specific transcriptional factors associated with neuronal loss in AD C_LI

neuroscience↗

A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease

The emergence of technologies that can support high-throughput profiling of single cell transcriptomes offers to revolutionize the study of brain tissue from persons with and without Alzheimers disease (AD). Integration of these data with additional complementary multiomics data such as genetics, proteomics and clinical data provides powerful opportunities to link observed cell subpopulations and molecular network features within a broader disease-relevant context. We report here single nucleus RNA sequencing (snRNA-seq) profiles generated from superior frontal gyrus cortical tissue samples from 101 exceptionally well characterized, aged subjects from the Banner Brain and Body Donation Program in combination with whole genome sequences. We report findings that link common AD risk variants with CR1 expression in oligodendrocytes as well as alterations in peripheral hematological lab parameters, with these observations replicated in an independent, prospective cohort study of ageing and dementia. We also observed an AD-associated CD83(+) microglial subtype with unique molecular networks that encompass many known regulators of AD-relevant microglial biology, and which are associated with immunoglobulin IgG4 production in the transverse colon. These findings illustrate the power of multi-tissue molecular profiling to contextualize snRNA-seq brain transcriptomics and reveal novel disease biology. The transcriptomic, genetic, phenotypic, and network data resources described within this study are available for access and utilization by the scientific community.

genomics↗